Najmul Hasan Forhad: A Simple Framework for Mastering Anticoagulant Therapy
Najmul Hasan Forhad, Medical Laboratory Technician at Doctors Without Borders, shared on LinkedIn:
”Hello ASCP Candidates,
I’m trying to represent all topics in an easy and simple way for your better understanding.
Here is an attachment about ‘Anticoagulant Therapy’ – a concise clinical framework covering platelet inhibitors, anticoagulants, and fibrinolytics.
This resource aims to make complex therapeutic concepts more accessible for students and professionals preparing for international medical laboratory certification.
It includes comparative notes on Warfarin, Heparin, Dabigatran, Rivaroxaban, and Apixaban, along with practical insights on PT/INR, APTT, and anti-Xa assays.
My goal is to simplify hematology and biochemistry topics through structured visuals and clear explanations – helping learners connect theory to clinical practice.”
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 16:36Piotr Czempik: Patient Blood Management Means Safer Care, Better Quality, and Responsible Resource Use
-
Apr 12, 2026, 16:31Eishi Asano: Available Evidence and Unmet Needs in EEG Use During Stroke Management
-
Apr 12, 2026, 16:23Jack Shuang Hou: CorTec Wins 1st-Ever FDA Breakthrough Device Designation for BCI in Stroke Motor Rehabilitation
-
Apr 12, 2026, 15:54Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
-
Apr 12, 2026, 15:38Hugo Antonio Romo Rubio: ASH ISTH 2026 Guidelines on Prophylactic Anticoagulation In Pediatrics
-
Apr 12, 2026, 15:26Melissa Lewellyn: The DVT and PE Awareness Resolution from NBCA Is Now Live
-
Apr 12, 2026, 14:58Akram Shibani: HI-PEITHO Trial Reminds Us Why Composite Endpoints Deserve Careful Scrutiny
-
Apr 12, 2026, 14:493 Days, 14 Leaders, 1 Mission at The 13th EHC Youth Leadership Workshop
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition